1:2:1 Podcast

Accelerated aging in women

A new study has found that for healthy women carrying a well-known genetic risk factor for Alzheimer's disease, estrogen therapy that could be beneficial. Women with the risk factor exhibited signs of accelerated biological aging. However, among at-risk women who used estrogen, the acceleration was absent. In this podcast, Natalie Rasgon, MD, PhD, director of the Stanford Center for Neuroscience in Women's Health and a senior author of the study, discusses the findings and how the research may help determine the types of women who might benefit from hormone therapy.

Length: 23 mins. 17 sec.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.